Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Revenue

Medeon Biodesign had revenue of 114.29M TWD in the quarter ending March 31, 2026, with 12.18% growth. This brings the company's revenue in the last twelve months to 431.84M, up 24.25% year-over-year. In the year 2025, Medeon Biodesign had annual revenue of 419.43M with 43.24% growth.

• Revenue (ttm): 431.84M
• Revenue Growth: +24.25%
• P/S Ratio: 16.55
• Revenue / Employee: 11.07M
• Employees: 39
• Market Cap: 7.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	419.43M	126.62M	43.24%
Dec 31, 2024	292.81M	96.55M	49.19%
Dec 31, 2023	196.26M	-102.05M	-34.21%
Dec 31, 2022	298.32M	229.36M	332.61%
Dec 31, 2021	68.96M	-54.10M	-43.96%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error